Working conference on biomodulator and chemotherapy combination therapies.
Brown
T D
TD
Department of Medicine/Oncology, University of Texas Health Science Center, San Antonio 78284.
Mitchell
M S
MS
Pazdur
R
R
Wadler
S
S
Weiss
G R
GR
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007370:Interferon Type I / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D014410:Tumor Stem Cell Assay / Q000379:methods
D000970:Antineoplastic Agents; D007155:Immunologic Factors; D007370:Interferon Type I; D007376:Interleukin-2; D005472:Fluorouracil